/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

NovoCure Limited Share Price Today: Live Updates & Key Insights

NovoCure Limited share price today is $11.83, up -2.8%. The stock opened at $12.14 against the previous close of $12.15, with an intraday high of $12.14 and low of $11.46.

NovoCure Limited Share Price Chart

style
pb-0

NovoCure Limited

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

NovoCure Limited Share Price Performance

$11.83 -0.028(-2.8%) NVCR at 23 Mar 2026 02:32 PM Medical Devices
Lowest Today 11.46
Highest Today 12.14
Today’s Open 12.14
Prev. Close 12.15
52 Week High 20.06
52 Week Low 9.82
Day’s Range: Low 11.46 High 12.14
52-Week Range: Low 9.82 High 20.06
1 day return -
1 Week return -4.63
1 month return +7.69
3 month return -11.98
6 month return -9.63
1 year return -40.24
3 year return -79.04
5 year return -91.59
10 year return -

NovoCure Limited Institutional Holdings

FMR Inc 14.76

BlackRock Inc 12.26

Vanguard Group Inc 9.63

Soleus Capital Management, L.P. 8.48

Fidelity Growth Compy Commingled Pl S 7.07

Fidelity Growth Company Fund 4.75

Vanguard Total Stock Mkt Idx Inv 2.95

State Street Corp 2.29

Geode Capital Management, LLC 2.18

iShares Russell 2000 ETF 2.17

Vanguard Small Cap Index 2.12

Fidelity Growth Company K6 1.52

Fidelity Series Growth Company 1.41

Quantinno Capital Management LP 1.34

Renaissance Technologies Corp 1.22

Vanguard Small Cap Growth Index Inv 1.18

Nuveen, LLC 1.12

Palo Alto Investors, LLC 1.10

Jacobs Levy Equity Management, Inc. 1.08

UBS Asset Mgmt Americas Inc 1.05

Baillie Gifford & Co Limited. 0.99

Vanguard Institutional Extnd Mkt Idx Tr 0.97

American Century Companies Inc 0.92

Schroder Investment Management Group 0.90

Fidelity Small Cap Index 0.88

CAM Group Holding A/S 0.85

C WorldWide Healthcare Select 1A 0.85

T. Rowe Price Investment Management,Inc. 0.83

HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 0.82

Morgan Stanley - Brokerage Accounts 0.81

The Goldman Sachs Group Inc 0.79

iShares Russell 2000 Growth ETF 0.74

iShares Biotechnology ETF 0.66

BGF World Healthscience A2 0.60

BlackRock Advantage Small Cap Core Instl 0.56

Nuveen Quant Small Cap Equity R6 0.55

State St Russell Sm/Mid Cp® Indx SL Cl I 0.53

BlackRock Health Sciences Opps Inv A 0.51

Fidelity Extended Market Index 0.46

Vanguard Explorer Inv 0.46

NovoCure Limited Market Status

Strong Buy: 3

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

NovoCure Limited Fundamentals

Market Cap 1343.91 M

PB Ratio 4.0576

PE Ratio 0.0

Enterprise Value 1183.28 M

Total Assets 804.33 M

Volume 1653056

NovoCure Limited Company Financials

Annual Revenue FY23:503983000 504.0M, FY22:537840000 537.8M, FY21:535031000 535.0M, FY20:494366000 494.4M, FY19:351318000 351.3M

Annual Profit FY23:379371000 379.4M, FY22:422973000 423.0M, FY21:420154000 420.2M, FY20:387865000 387.9M, FY19:262712000 262.7M

Annual Net worth FY23:-197267000 -197.3M, FY22:-92534000 -92.5M, FY21:-58351000 -58.4M, FY20:19808000 19.8M, FY19:-7230000 -7.2M

Quarterly Revenue Q3/2025:167204000 167.2M, Q2/2025:158805000 158.8M, Q1/2025:154994000 155.0M, Q3/2024:155095000 155.1M, Q2/2024:150356000 150.4M

Quarterly Profit Q3/2025:122475000 122.5M, Q2/2025:117333000 117.3M, Q1/2025:116473000 116.5M, Q3/2024:119723000 119.7M, Q2/2024:115702000 115.7M

Quarterly Net worth Q3/2025:-37270000 -37.3M, Q2/2025:-40139000 -40.1M, Q1/2025:-34319000 -34.3M, Q3/2024:-30570000 -30.6M, Q2/2024:-33375000 -33.4M

About NovoCure Limited & investment objective

Company Information NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Organisation Medical Devices

Employees 1605

Industry Medical Devices

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

NovoCure Limited FAQs

What is the share price of NovoCure Limited today?

The current share price of NovoCure Limited is $11.83.

Can I buy NovoCure Limited shares in India?

Yes, Indian investors can buy NovoCure Limited shares by opening an international trading and demat account with Motilal Oswal.

How to buy NovoCure Limited shares in India?

You can easily invest in NovoCure Limited shares from India by:

Can I buy fractional shares of NovoCure Limited?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NovoCure Limited?

NovoCure Limited has a market cap of $1343.91 M.

In which sector does NovoCure Limited belong?

NovoCure Limited operates in the Medical Devices sector.

What documents are required to invest in NovoCure Limited stocks?

To invest, you typically need:

What is the PE and PB ratio of NovoCure Limited?

The PE ratio of NovoCure Limited is N/A and the PB ratio is 4.06.